Phibro Animal Health Corporation

Tvardi Therapeutics (NASDAQ: TVRD - Get Free Report) and Phibro Animal Health (NASDAQ: PAHC - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends and earnings. Insider and Institutional Ownership 44.7% of

SEI, SDRL and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 21st, 2026.

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?

Engineers Gate Manager LP boosted its position in Phibro Animal Health Corporation (NASDAQ: PAHC) by 112.8% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 52,914 shares of the company's stock after purchasing an additional 28,052 shares during the quarter.